What is NuScience Peptides
The program has expanded from primarily US-based companies to include international participants from Ireland, Vietnam, India, and other markets, signaling that Mayo sees clinical AI as a global opportunity
Much of the work government does involves precisely those actions
GLP-1s show a clear kidney protective signal in patients with T2D associated CKD Novo Nordisks FLOW trial provided the field with the first dedicated, convincing evidence that semaglutide, known under the brand name Ozempic, can slow renal decline, with its 24% placebo-adjusted reduction in a composite kidney endpoint across 3,533 adults with T2D and CKD
The combined anti-inflammatory effect could accelerate the metabolic improvements that take weeks or months to manifest with either compound alone